| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Immunology | 160 | 16 | 18 | 11 |
| Medicine | 1148 | 64 | 61 | 21 |
BioDrugs tackles a plethora of topics, such as Pharmacotherapy, Immunology, Internal medicine, Antibody and Pharmacology. It explores research in Pharmacotherapy alongside concepts in Molecular medicine and other areas of study in Cancer research. BioDrugs facilitated presentations on Immunology research, particularly Immune system, Rheumatoid arthritis, Antigen, Monoclonal antibody and Cytokine.
It features studies on Immune system, including topics such as Immunotherapy. In it, Infliximab and Arthritis are investigated in conjunction with one another to address concerns in Rheumatoid arthritis research. The research on Internal medicine featured in BioDrugs combines topics in other fields like Gastroenterology, Endocrinology and Oncology.
The work on Oncology tackled in it brings together disciplines like Cancer, Breast cancer and Chemotherapy. Most of the works presented in BioDrugs deals with Antibody but it intersects with the subject of Virology. The subject of Biosimilar, which is connected to the field of MEDLINE, serves as the foundation of the Pharmacology research featured in it.
The published papers investigate studies in Immunology, Pharmacology, Antibody, Internal medicine and Immune system. The journal articles tackle studies in Biosimilar and the interrelated subject of Risk analysis (engineering) to gain insights into Pharmacology. While Internal medicine is the key highlight in the most cited papers, thet also covered some subjects on Oncology and Cancer.
BioDrugs mainly tackles studies in Internal medicine, Pharmacotherapy, Biosimilar, Adverse effect and Oncology. The studies on Pharmacotherapy discussed can also contribute to research in the domains of Genome editing, Cancer, Chimeric antigen receptor and Adverse Event Reporting System. It explores issues in Biosimilar which can be linked to other research areas like Marketing, Health care, MEDLINE and Intensive care medicine.
Oncology research featured in the journal incorporates concerns from various other topics such as Breast cancer, Metastatic breast cancer, Trastuzumab, Immunogenicity and Immunotherapy. In addition to Clinical trial research, it aims to explore topics under Pathogenesis, Molecular medicine, Retinal pigment epithelium, Tyrosine kinase and Antibody. The Immunology study tackled is a key component of adjacent topics in the area of Disease.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in BioDrugs (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in BioDrugs (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.52% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.95% were posted by at least one author from the top 10 institutions publishing in the journal. Another 18.60% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.63% of all publications and 55.81% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Małgorzata Łobocka;Krystyna Dąbrowska;Andrzej Górski
(2021)Ahmed Almradi;Jurij Hanzel;Rocio Sedano;Claire E Parker
(2020)Salvatore Crisafulli;Valentina Isgrò;Laura La Corte;Fabiola Atzeni
(2020)Ami Patel;Mamadou A Bah;David B Weiner
(2020)Steven J Bots;Claire E Parker;Johannan F Brandse;Mark Löwenberg
(2021)Pursuing a career in medicine often opens doors to various related fields that can be explored through online education. Many students interested in healthcare start by considering nursing colleges that don’t require SAT, offering flexible pathways into nursing without the barrier of standardized entrance exams.
For those aspiring to move into healthcare management, affordable options are available through the cheapest MHA programs. These programs prepare graduates for leadership roles within hospitals and health organizations, balancing clinical knowledge with administrative skills.
If you’re looking to enter clinical practice quickly, online fastest LPN program options can provide expedited routes to Licensed Practical Nurse licensure, enabling faster entry into patient care roles.
For advanced educators in nursing, pursuing a doctorate in nursing education online programs offers an affordable way to reach the highest levels of academia and contribute to training the next generation of nurses.
